Literature DB >> 15106085

Defining and assessing measles elimination goals.

Mark J Papania1, Walter A Orenstein.   

Abstract

Although 3 of 6 World Health Organization regions have established measles elimination targets, measles elimination goals are not well defined. In general, disease elimination has been defined as the reduction of incidence in a population to zero. However, measles is so contagious that zero incidence is difficult to achieve and sustain because the risk of imported measles remains while measles is endemic in any country. Also, imported cases will occasionally result in short chains of indigenous transmission unless a country achieves 100% immunity. Therefore, the United States currently uses the absence of endemic measles (i.e., no indigenous chains of transmission persisting for >or=1 year) as the programmatic goal for measles elimination. To document the absence of endemic measles in the United States, we compiled information on the epidemiology of measles, genotype distribution, population immunity, and adequacy of measles surveillance. A panel of experts, convened in March 2000 to review the data, concluded that measles is no longer endemic in the United States.

Mesh:

Year:  2004        PMID: 15106085     DOI: 10.1086/381556

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  Elimination of endemic measles transmission in Australia.

Authors:  Anita E Heywood; Heather F Gidding; Michaela A Riddell; Peter B McIntyre; C Raina MacIntyre; Heath A Kelly
Journal:  Bull World Health Organ       Date:  2009-01       Impact factor: 9.408

2.  Identifying postelimination trends for the introduction and transmissibility of measles in the United States.

Authors:  Seth Blumberg; Wayne T A Enanoria; James O Lloyd-Smith; Thomas M Lietman; Travis C Porco
Journal:  Am J Epidemiol       Date:  2014-04-30       Impact factor: 4.897

3.  Maintaining measles elimination in Canada: Moving forward.

Authors:  P Lam; L Williams; S Gadient; S Squires; M St-Laurent
Journal:  Can Commun Dis Rep       Date:  2015-07-02

4.  Revealing new measles virus transmission routes by use of sequence analysis of phosphoprotein and hemagglutinin genes.

Authors:  Julia R Kessler; Jacques R Kremer; Sergey V Shulga; Nina T Tikhonova; Sabine Santibanez; Annette Mankertz; Galina V Semeiko; Elena O Samoilovich; Jean-Jacques Muyembe Tamfum; Elisabeth Pukuta; Claude P Muller
Journal:  J Clin Microbiol       Date:  2010-11-24       Impact factor: 5.948

Review 5.  How absolute is zero? An evaluation of historical and current definitions of malaria elimination.

Authors:  Justin M Cohen; Bruno Moonen; Robert W Snow; David L Smith
Journal:  Malar J       Date:  2010-07-22       Impact factor: 2.979

6.  Incidence of Measles in the United States, 2001-2015.

Authors:  Nakia S Clemmons; Gregory S Wallace; Manisha Patel; Paul A Gastañaduy
Journal:  JAMA       Date:  2017-10-03       Impact factor: 56.272

7.  Comparative seroprevalence of measles virus immunoglobulin M antibodies in children aged 0-8 months and a control population aged 9-23 months presenting with measles-like symptoms in selected hospitals in Kaduna State.

Authors:  A E Olaitan; E E Ella; J B Ameh
Journal:  Int J Gen Med       Date:  2015-03-10

8.  Molecular epidemiology of measles virus in Italy, 2002-2007.

Authors:  Fabio Magurano; Claudia Fortuna; Antonella Marchi; Eleonora Benedetti; Paola Bucci; Melissa Baggieri; Loredana Nicoletti
Journal:  Virol J       Date:  2012-11-23       Impact factor: 4.099

9.  Genetic characterization of measles viruses in China, 2004.

Authors:  Yan Zhang; Yixin Ji; Xiaohong Jiang; Songtao Xu; Zhen Zhu; Lei Zheng; Jilan He; Hua Ling; Yan Wang; Yang Liu; Wen Du; Xuelei Yang; Naiying Mao; Wenbo Xu
Journal:  Virol J       Date:  2008-10-20       Impact factor: 4.099

10.  Molecular epidemiology of measles viruses in China, 1995-2003.

Authors:  Yan Zhang; Zhen Zhu; Paul A Rota; Xiaohong Jiang; Jiayu Hu; Jianguo Wang; Wei Tang; Zhenying Zhang; Congyong Li; Changyin Wang; Tongzhan Wang; Lei Zheng; Hong Tian; Hua Ling; Chunfang Zhao; Yan Ma; Chunyan Lin; Jilan He; Jiang Tian; Yan Ma; Ping Li; Ronghui Guan; Weikuan He; Jianhui Zhou; Guiyan Liu; Hong Zhang; Xinge Yan; Xuelei Yang; Jinlin Zhang; Yiyu Lu; Shunde Zhou; Zhuoma Ba; Wei Liu; Xiuhui Yang; Yujie Ma; Yong Liang; Yeqiang Li; Yixin Ji; David Featherstone; William J Bellini; Songtao Xu; Guodong Liang; Wenbo Xu
Journal:  Virol J       Date:  2007-02-05       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.